Sichuan Hebang Biotechnology Corporation Limited (SHA: 603077)

Sichuan Hebang Biotechnology Corporation Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2,567	3,064	4,591	1,711	845.86	590.52
Trading Asset Securities	-	-	-	56.89	-	206.03
Cash & Short-Term Investments	2,567	3,064	4,591	1,768	845.86	796.55
Cash Growth	-33.89%	-33.26%	159.70%	109.01%	6.19%	-41.94%
Accounts Receivable	2,821	2,049	2,568	1,656	1,682	1,121
Other Receivables	71.16	34.35	23.09	19.55	14.75	27.67
Receivables	2,892	2,084	2,591	1,675	1,697	1,149
Inventory	4,916	4,403	2,076	912.2	633.27	1,318
Other Current Assets	454.05	303.87	460.25	287.84	141.95	228.77
Total Current Assets	10,828	9,855	9,719	4,643	3,318	3,492
Property, Plant & Equipment	9,811	9,684	9,483	8,295	7,513	7,165
Long-Term Investments	819.36	667.27	677.37	661.99	645.59	369.25
Goodwill	1,838	1,838	1,838	1,904	1,904	1,904
Other Intangible Assets	2,174	2,200	2,143	1,967	1,018	1,088
Long-Term Deferred Tax Assets	59.15	50.38	110.3	25.83	85.94	38.7
Long-Term Deferred Charges	159.24	105.46	34.01	7.29	9.85	9.73
Other Long-Term Assets	286.44	142.16	97.84	417.19	245.29	417.62
Total Assets	25,975	24,542	24,103	17,922	14,740	14,484
Accounts Payable	2,748	1,877	1,877	1,156	1,042	971.08
Accrued Expenses	52.33	107.61	91.37	126.24	79.69	76.44
Short-Term Debt	2,230	1,168	1,222	1,171	1,602	1,593
Current Portion of Long-Term Debt	577.35	342.32	164	95	279	35.24
Current Portion of Leases	-	2.44	2.44	-	-	-
Current Income Taxes Payable	42.14	55.01	95.71	140.79	21.78	28.41
Current Unearned Revenue	75.42	96.6	235.07	371.54	113.74	1.28
Other Current Liabilities	36.36	20.83	46.5	62.07	13.87	79.02
Total Current Liabilities	5,762	3,670	3,734	3,123	3,152	2,785
Long-Term Debt	604.29	431.17	408.48	68.09	262.4	226
Long-Term Leases	28.08	24.94	21.54	37.06	-	-
Long-Term Unearned Revenue	69.82	75.25	79.03	16.79	15.86	17.15
Long-Term Deferred Tax Liabilities	130.11	122.75	96.02	39.99	2.3	2.96
Total Liabilities	6,595	4,324	4,339	3,285	3,433	3,031
Common Stock	8,831	8,831	8,831	8,831	8,831	8,831
Additional Paid-In Capital	1,153	1,125	1,095	470.46	212.9	212.9
Retained Earnings	10,429	10,204	9,313	5,642	2,619	2,578
Treasury Stock	-1,690	-650.37	-150	-700	-520.07	-400
Comprehensive Income & Other	41.43	66.4	29.45	1.9	-1.24	11.31
Total Common Equity	18,765	19,575	19,118	14,245	11,142	11,233
Minority Interest	616.09	643.04	644.86	391.84	165.66	219.53
Shareholders' Equity	19,381	20,218	19,763	14,637	11,307	11,453
Total Liabilities & Equity	25,975	24,542	24,103	17,922	14,740	14,484
Total Debt	3,440	1,969	1,818	1,372	2,144	1,855
Net Cash (Debt)	-873.33	1,096	2,773	396.4	-1,298	-1,058
Net Cash Growth	-	-60.49%	599.57%	-	-	-
Net Cash Per Share	-0.10	0.13	0.32	0.05	-0.15	-0.12
Filing Date Shares Outstanding	8,025	8,512	8,725	8,394	8,518	8,606
Total Common Shares Outstanding	8,025	8,512	8,725	8,394	8,518	8,606
Working Capital	5,066	6,185	5,985	1,520	165.62	706.8
Book Value Per Share	2.34	2.30	2.19	1.70	1.31	1.31
Tangible Book Value	14,753	15,537	15,137	10,374	8,219	8,241
Tangible Book Value Per Share	1.84	1.83	1.73	1.24	0.96	0.96
Buildings	-	3,564	2,856	-	2,065	1,960
Machinery	-	11,677	10,357	-	7,313	6,732
Construction In Progress	-	1,174	1,885	-	2,320	2,087

Source: S&P Capital IQ. Standard template. Financial Sources.